1Baccala AA, Zhong H, Clift SM, Nelson WG, Marshall FF,Passe TJ, Gambill NB, Simons JW. Serum Vascular endothelial growth factor is a candidate biomarker of metastatic tumor response to ex vivo gene therapy of renal cell cancer.Urology 1998;51:327-332.
2Mineta H, Miura K, Ogino T, Takebayashi S, Misawa K, Ueda Y, Suzuki I, Dictor M, Borg A, Wennerberg J. Prognostic value of Vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas. Br J Cancer 2000; 83:775-781.
3Brockmann JG, St Nottberg H, Glodny B, Sprakel B, Senninger N. Analysis of serum CYFRA 21-1 concentrations in patients with esophageal cancer. Anticancer Res 2000;20:4899-4904.
5Shimada H, Takeda A, Arima M, Okazumi S, Matsubara H,Nabeya Y, Funami Y, Hayashi H, Gunji Y, Suzuki T,Kobayashi S, Ochiai T. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma.Cancer 2000;89:1677-1683.
